EADV Task Forces

What are Task Forces and what do they do?

EADV Task Forces (TFs) are groups of specialists in different fields of dermatology and venereology that bring together a specific set of skills and expertise to enable EADV to influence and advance research and knowledge on subjects with scientific, clinical or educational relevance.

Each task force is focused on a specialty area of dermato-venereology and can be considered a “centre of excellence”, internal to EADV, playing a crucial role in fostering and advancing medical and patient education, information, communication on latest advances, cutting-edge studies, discoveries and expert opinion statements.

TFs also promote innovation by stimulating the initiation of projects and proposals related to their area of expertise. They also play an advisory role to EADV regarding trends or unmet needs in clinical practice, education and research in or advocacy for dermatology and venereology.

Task Forces perform the following main duties:

Develop medical and patient educational materials
Support the EADV in the organisation of scientific sessions, online or face-to-face courses within their area of expertise
Allow the EADV to influence awareness and information on matters related to special fields within dermato-venereology (e.g. by reviewing and/or producing evidence-based guidelines for clinical practice, preparing position statements and/or providing expert opinion)
Develop proposals or projects for consideration by the Project Proposal Review Committee (PPRC) or seek funding by other agencies to instigate and conduct studies in their area of expertise.
Make Speaker and cutting-edge topics suggestions to the EADV Scientific Programming Committee (SPC) for Congresses and Symposia

Moreover, they may:

Serve as contact to other EADV Committees when necessary
Propose and/ or be involved in research projects (e.g. EU projects, multicenter trials etc.)
Organise small meetings (with maximum 20 participants) during the annual EADV events (Symposium and/or Congress) *

* Exception: the “European Task Force Atopic dermatitis” (ETFAD) was an already existing Subspecialty Society with own rules which put itself under the patronage of EADV as “Eczema Task Force”; therefore, ETFAD maintains the right to propose its own Subspecialty meeting at EADV congresses. This right was not automatically granted to the other Task Forces.

How are Task Forces regulated?

Task Forces are regulated by a set of principles detailed in the form of bylaws.

Click here to read the Task Force Bylaws currently in force and refer to them for guidance to Task Forces’ aims, duties, practices and principles.

Bylaws were first approved by the Board in 2015 and have been subsequently updated in 2020 and 2025.

Task Forces are coordinated and overseen in their activities by an elected Task Force Facilitator (TFF). The TFF receives administrative support to oversee Task Forces by the EADV TF Office, and fulfils the following roles:

Review the initial application and the annual report of TFs.
Compose reports to the EC/Board on the initiation, status and progress of TFs.
Co-ordinate and mediate the interaction of TFs with EC/Board/Committees.
Review the content of any material produced by TFs.
Assess any specific requests by TFs and make requisite proposals to the EC/Board.

The TFF is elected by the EADV Board for a four-year term and shall serve a maximum of one term of office.

Are you interested in joining a Task Force?

To apply for membership to one or more EADV Task Forces, you are kindly requested to provide your CV and a letter of motivation.

Please be informed that, to formally apply for inclusion in one or more EADV Task Forces, the EADV membership of the applicant should be active for the present year.

Application iter: inclusion of new Task Force members is subject to a first review by the Task Force Facilitator (TFF) and subsequent discussion/ voting by the TF members.

The outcome of each application is communicated by the TF Chair/ Co-Chair after the TF has discussed and voted on the application.

A Task Force is a small group that brings together a specific set of skills and ideas to accomplish distinct projects of scientific, clinical or educational relevance in the speciality of dermato-venereology.

All Task Forces work under the umbrella of the EADV and report to the Task Force Facilitator who guides and oversees the Task Forces, mediates with the chairs, helps to develop your strategy in line with the EADV mission, reviews outcomes, and prepares the annual report on performed activities.

EADV Task Forces Bylaws

Please click here to read the official Task Force Bylaws and refer to them for guidance to Task Force practices and principles.

Bylaws were first approved by the Board in 2015, and have been updated in 2020 and 2025.

Aims and duties of the EADV Task Forces

The Board implemented Task Forces in 2005 to perform the following main duties

make speaker suggestions to the Scientific Programming Committee for Congresses and Symposia
develop educational materials
allow the EADV to influence and keep updated information on matters related to special fields within dermato-venereology

Moreover, they may

be involved in preparation of guidelines or JEADV review articles
serve as contact to other committees when necessary
build a platform for common research projects (e.g. EU projects, multicenter trials etc.);
organise small meetings (with maximum 20 participants) during the annual Congress

Furthermore, the following rules for the Task Force activities were given:“The work of the EADV Task Forces is voluntary, their size is flexible. The Task Forces are principally open to all members interested. There is no inherent financial support connected with the work of Task Forces. However, they can ask for support regarding specific projects.”Task Force leaders initial term of office will last four years (extended by 4 years by consensus decision or by the Board). Task Forces can be dismissed when there is no apparent activity.*There is only one exception: the “European Task Force Atopic dermatitis” (ETFAD) was an already exisiting Subspecialty Society with own rules which put itself under the patronage of EADV as “Eczema Task Force”; the EADV TF coordinators were the same as the chairpersons of the ETFAD, namely Ulf Darsow and Alain Taïeb. Therefore ETFAD had a right to propose their own Subspecialty meeting on Wednesday at our congresses. This right was not automatically granted to the other Task Forces.

Read all the positions statements from EADV's Task Forces

List of EADV Task Forces

Acne / Rosacea / Hidradenitis Suppurativa

Christos C. Zouboulis	Germany	Chair
Gregor Jemec	Denmark	Co-chair
Martin Steinhoff	Germany	Co-chair

Advocacy

Myrto Trakatelli	Greece	Chair
Catherine van Montfrans	Netherlands	Co-chair
Aleksandra Lesiak	Poland	Co-chair

Artificial Intelligence in Dermatology

Joseph Malvehy	Spain	Chair
Giovanni Pellacani	Italy	Co-chair
Harald Kittler	Austria	Co-chair

Autoimmune Blistering Diseases

Enno Schmidt	Germany	Chair
Katerina Patsatsi	Greece	Co-chair

Climate

Hok Bing Thio	Netherlands	Chair
David de Berker	United Kingdom	Co-chair
Dennis Niebel	Germany	Co-chair

Contact Dermatitis

Ana Gimenez-Arnau	Spain	Chair
Ana Balato	Italy	Co-chair
Suzana Ljubojevic	Croatia	Co-chair

Cosmetic Dermatology

Christopher Rowland Payne	United Kingdom	Chair
Emanuel Carvalheiro Marques	Portugal	Co-chair
Pierre Andre	France	Co-chair

Cutaneous adverse reactions to drugs and erythema multiforme (CARD-EM)

Saskia Oro	France	Chair
Sarah Walsh	United Kingdom	Co-chair
Marie-Charlotte Brüggen	Switzerland	Co-chair

Dermatology for Cancer Patients

Vincent Sibaud	France	Chair
Azael Freites-Martinez	Spain	Co-chair
Zoe Apalla	Greece	Co-chair

Dermatopathology

Franco Rongioletti	Italy	Chair
Maria Teresa Fernandez-Figueras	Spain	Co-chair

Eczema / Atopic Dermatitis

Magda Trzeciak	Poland	Chair
Dirk Jan Hijnen	Netherlands	Co-chair
Andreas Wollenberg	Germany	Co-chair

Epidemiology

Marlies Wakkee	Netherlands	Chair
Emilie Sbidian	France	Co-chair
Clio Dessinioti	Greece	Co-chair

Genodermatoses

Johann Bauer	Austria	Chair
Christine Bodemer	France	Co-chair

Geriatric Dermatology

Ümit Türsen	Türkiye	Chair
Monika Fida	Albania	Co-chair

Hair Diseases

Michela Starace	Italy	Chair
Matilde Iorizzo	Switzerland	Co-chair
Alexandros Katoulis	Greece	Co-chair

History of Dermatology

Michael Geiges	Switzerland	Chair
Chukwudi Nwabudike	Romania	Co-chair

HPV Infection

Mihael Skerlev	Croatia	Chair
Arne Vikström	Sweden	Co-chair

Laser Dermatology and Energy Based Devices (EBD)

Ashraf Badawi	Egypt	Chair
Albert Wolkerstorfer	Netherlands	Co-chair
Hans-Joachim Laubach	Switzerland	Co-chair

Melanoma

Monika Arenbergerova	Czech Republic	Chair
Ketty Peris	Italy	Co-chair

Mycology

Ditte Marie Saunte	Denmark	Chair
Carmen Rodriguez – Cerdeira	Spain	Co-chair
Roderick James Hay	United Kingdom	Co-chair

Non-Melanoma Skin Cancer

Mahtab Samimi	France	Chair
Ettore Minutilli	Italy	Co-chair
Myrto Trakatelli	Greece	Co-chair

Nurses in Dermatology

Sheila Ryan	Ireland	Chair
Elfie Deprez	Belgium	Co-chair

Occupational Skin Disease

Swen Malte John	Germany	Chair
Thomas Rustenmeyer	Netherlands	Co-chair

Office Management

Monika Gniadecka	Denmark	Chair
Georges Reuter	France	Co-chair
Rolf Ostendorf	Germany	Co-chair

Paediatric Dermatology

Dirk Van Gysel	Belgium	Chair
Suzanne Pasmans	Netherlands	Co-chair
Vincenzo Piccolo	Italy	Co-chair

Phlebology

Felizitas Pannier	Germany	Chair
Dr. Liselot Vink	Netherlands	Co-chair
George Sorin Tiplica	Romania	Co-chair

Photodermatology

Piergiacomo Calzavara Pinton	Italy	Chair
Jean Krutmann	Germany	Co-chair
Marjan Garmyn	Belgium	Co-chair

Pruritus

Sonja Ständer	Germany	Chair
Adam Reich	Poland	Co-chair
Evangelia Papadavid	Greece	Co-chair

Psoriasis

Jo Lambert	Belgium	Chair
Luis Puig	Spain	Co-chair

Psychodermatology

Laurent Misery	France	Chair
Antony Bewley	United Kingdom	Co-chair
Flora Balieva	Norway	Co-chair

Quality of Life and Patient-Oriented Outcomes

Pavel Chernyshov	Ukraine	Chair
Liana Manolache	Romania	Co-chair

Sexually Transmitted Infections (STI)

George Sorin Tiplica	Romania	Chair
Derek Freedman	Ireland	Co-chair

Skin Ageing

Gürkan Kaya	Switzerland	Chair
Joachim Fluhr	Germany	Co-chair

Skin and pollution

Giovanni Damiani	Italy	Chair
Dennis Niebel	Germany	Co-chair

Skin Diseases in Pregnancy

Julia-Tatjana Maul	Switzerland	Chair
Brigitte Stephan	Germany	Co-chair
Sara Pruneddu	United Kingdom	Co-chair

Skin in Organ Transplant Recipients (OTRs)

Alexandra Geusau	Austria	Chair
Carla Ferrandiz-Pulido	Spain	Co-chair
Mirjam Nägeli	Switzerland	Co-chair

Sports Dermatology

Nicolas Kluger	Finland	Chair
Stéphanie Leclerc-Mercier	France	Co-chair

Tattoos and Body Art

Christa de Cuyper	Belgium	Chair
Patrycja Rogowska	Poland	Co-chair
Hugues Cartier	France	Co-chair

Teledermatology

Linda Tognetti	Italy	Chair
Elvira Moscarella	Italy	Co-chair
Paola Pasquali	Spain	Co-chair

Tropical Dermatology

Rüdiger Panzer	Germany	Chair
Niels Horst	Netherlands	Co-chair
Lara Maul-Duwendag	Switzerland	Co-chair

Urticaria / Angioedema

Torsten Zuberbier	Germany	Chair
Emek Kocatürk	Türkiye	Co-chair

Vasculitis and Vasculopathy

Cord Sunderkötter	Germany	Chair
Erkan Alpsoy	Türkiye	Co-chair
Marzia Caproni	Italy	Co-chair

Vitiligo

Nanja Van Geel	Belgium	Chair
Julien Seneschal	France	Co-chair

Wound Healing

Marco Romanelli	Italy	Chair
Anne Dompmartin-Blanchere	France	Co-chair
Jürg Hafner	Switzerland	Co-chair